To evaluate the spectrum of nocardiosis after marrow transplantation, we reviewed the medical records of 27 patients with nocardiosis who were treated at three centers, and we reviewed the findings of three cases reported in the literature. Nocardial involvement was defined as invasive nocardiosis (n Å 25), colonization (n Å 4), or contamination (n Å 1). The median time to the diagnosis of nocardiosis after marrow transplantation was 210 days. Nocardia asteroides complex accounted for 96% of isolates. All 25 invasive infections occurred in allogeneic marrow recipients. Ten (40%) of 25 patients with invasive nocardiosis were receiving double-strength oral trimethoprimsulfamethoxazole twice weekly as prophylaxis for Pneumocystis carinii pneumonia. Treatment regimens for nocardiosis included sulfonamides; synergistic agents were also often added. The overall survival rate at 6 years was 34%; survival from the infection itself was 84%. Two of four nocardiosisrelated deaths also involved other pathogens. The incidence of nocardiosis among allogeneic marrow recipients averaged 0.3% over 25 years. We conclude that nocardiosis is a rare infection that occurs later after marrow transplantation than other infections and that is marginally associated with increased mortality among long-term survivors of allogeneic marrow transplantation.
Nocardiosis is an uncommon infection after marrow transdiscaviarum (formerly N. caviae [5] ) (3%), and unidentified Nocardia species (10%) [6] . The patients in the study were plantation despite the profound immunosuppression that results from antineoplastic chemotherapy and the administration of predominantly male [6, 7] . Nocardia species can be saprobes of the respiratory tract corticosteroids [1 -4] . Nocardia species, which are gram-positive aerobic actinomycetes belonging to the family Nocardiaand are rarely reported as laboratory contaminants [8] . Patients with cancer can become colonized, as is suggested when spuceae, are found worldwide in soil and decaying organic matter. Human infection with these organisms was first described in tum cultures are positive but chest radiographs are negative [9] or multiple cultures are positive in the absence of objective 1890.
Underlying conditions associated with nocardiosis include pulmonary findings [10] . The incidence of nocardiosis among solid-organ transplant recipients has varied from 0.7% to 3.7% corticosteroid use, antineoplastic chemotherapy, solid-organ transplantation, AIDS, pulmonary alveolar proteinosis, tuberat kidney transplantation centers [11, 12] and liver transplantation centers [13] , and an incidence of 9.9% or 13% has been culosis, chronic granulomatous disease, diabetes mellitus, and alcoholism. According to the results of a survey conducted in reported for heart transplant recipients [14, 15] . The incidence among marrow transplant recipients has not been defined. the United States from 1972 to 1974, the most common isolates in cases of pulmonary or systemic nocardiosis were Nocardia Only four cases of nocardiosis in marrow transplant patients have been reported in the English-language literature (acasteroides (81%), Nocardia brasiliensis (6%), Nocardia otiticording to a MEDLINE search since 1966) [1 -4] . To describe the incidence, clinical presentation, and medical and/or adjunctive surgical treatment of nocardiosis and to evaluate the Statistical analysis. The day of onset of nocardia infection through the transplantation procedure.
At FHCRC, cases were identified by reviewing culture rewas defined as the day on which the initial isolate of Nocardia was recovered or the histopathologic specimen was obtained, sults, patient records for discharge diagnoses, and databases containing information on long-term follow-up. At HLMCC, or as the date of death when the diagnosis was made at autopsy. The day of serological diagnosis was the date of a positive cases were identified by searching the microbiology laboratory database. At MSKCC, cases were identified by a computer microimmunodiffusion test. We examined associations in 2 1 2 tables by using Fisher's exact test. We estimated the 6-search of databases containing microbiological and pathological and/or cytological information and discharge diagnoses.
year posttransplantation survival of allogeneic transplant recipients at FHCRC with a Kaplan-Meier curve and made compariFour cases of invasive nocardiosis following marrow transplantation were reported in the literature between 1966 and sons by using the logrank test. For each case, we selected the four controls who underwent transplantation at the time that 1995; we also reviewed the findings in these cases [1 -4] . (One of these cases is included among the FHCRC cases).
was closest to the time that the case underwent transplantation (72 days maximum difference). Another requirement for selecDefinitions. We constructed the following case definitions before reviewing the charts of patients with evidence of nocartion of controls was that the control patient was still alive at the time nocardiosis was diagnosed in the corresponding case. diosis. Proven nocardiosis was defined as the presence of Nocardia species in culture or on histopathologic examination of a clinical specimen obtained from a normally sterile site (including subcutaneous abscesses) and a compatible clinical Results presentation. Probable nocardiosis was defined as recovery of Nocardia species from bronchoalveolar lavage (BAL) fluid, Cases. We evaluated a series of 30 cases of nocardiosis, including 27 cases that occurred among 6,759 patients who sputum, or a tracheal aspirate and a clinical or radiographic presentation compatible with nocardiosis. A fourfold or greater underwent transplantation at three centers in different geographic regions (Washington, New York, and Florida) and three increase in antibodies to Nocardia-species (as determined by microimmunodiffusion) between the acute-phase and convalescases from the literature, which also occurred in different geographic regions (Michigan, Texas, and Japan). We reviewed cent-phase serum samples and clinical evidence of infection in the absence of positive cultures [16] was also defined as probathe 25 cases of invasive disease that were either proven or probable. Ninety-two percent of the invasive cases were diagble infection. Cutaneous nocardiosis was defined as recovery of a Nocardia species from an abscess or a swab of a catheter nosed on the basis of a positive culture. Invasive procedures, which were performed in 21 of 25 cases, established the diagnoexit site and a clinical presentation compatible with bacterial infection. Colonization was defined as a positive culture of a sis in 18 (72%) of the 25 cases. The remaining five patients (one of whom received an autologous transplant) without docuspecimen from a nonsterile site in the absence of clinical evidence of infection. Contamination was defined as recovery of mented infection were either colonized (n Å 4) or had an isolate that was designated as a contaminant (n Å 1). No further Nocardia species from a normally sterile site in the absence of a compatible clinical or radiographic presentation.
analysis was performed for these patients.
Demographics. The 25 patients with proven or probable Episodes of neutropenia and active GVHD (acute or chronic) that occurred in the 2 weeks before the diagnosis of nocardiosis infection were older (age, ú18 years for 72%), and more than half (68%) were male. The mean age ({SD) at onset of nocarwere considered potential predisposing factors for the development of nocardiosis. In addition, since trimethoprim-sulfadiosis was 36 years { 17 years (range, 5 -62 years). Oncological diagnoses included chronic myelogenous leukemia in the methoxazole is active against Nocardia species, its use in marrow transplant recipients as prophylaxis for (table 1) . tion were diagnosed among the 6,759 patients who underwent N. asteroides complex was recovered from blood (n Å 4), the transplantation at three centers during the relevant periods, for respiratory tract (n Å 13), brain abscesses (n Å 2), and skin an incidence of 0.3%. The incidence of nocardiosis varied (n Å 9). The two patients with brain abscesses did not have slightly by institution: at FHCRC, it was 0.3% (18 of 5,507
Nocardia isolated from other sites. The multiple isolates recovtransplant recipients); at MSKCC, it was 0.1% (1 of 836); and ered from six patients were identical species. Partial drug susat HLMCC, it was 0.7% (3 of 416). The literature search receptibility data were available for seven isolates; however, testvealed three additional cases. Twenty-six percent of the nocaring by the Kirby-Bauer disk diffusion method with diosis cases occurred between day 51 and day 100 after marrow cefamandole or tobramycin, which would have permitted furtransplantation, but the infection can also occur much later ther differentiation of N. asteroides complex into N. asteroides, (figure 1). Infection developed only in allogeneic transplant Nocardia farcinica, or Nocardia nova, was not done. recipients; none of the 344 second-time recipients or the 12
Pulmonary infection attributable to Nocardia occurred in 14 third-time recipients at FHCRC developed nocardiosis during cases of invasive disease (56%) (table 1) and manifested on the study period.
chest radiographs as nodules (n Å 9), infiltrates (n Å 2), or The risk for infection among the 4,570 allogeneic transplant recipients at FHCRC was 14,101 person-years, for a rate of 0.0013 infections per year after transplantation. At FHCRC, 572/mm 3 . Patient 11 had ganciclovir-induced neutropenia between days 73 and 83; nocardiosis was diagnosed on day 89. Patient 13 developed pulmonary nocardiosis on day 17 before both (n Å 3) (table 2). There was no consistent pattern of symptoms, although four patients reported right-sided pleuritic transplantation, at which time he had neutropenia due to myelodysplastic syndrome. chest pain, and three reported a nonproductive cough. N. asteroides complex was isolated in culture for 11 of these patients, One hundred-seven (4%) of 2,704 controls at FHCRC were neutropenic for 14 consecutive days after normal engraftment, and one case each was diagnosed by culture (N. otitidiscaviarum), histopathology at autopsy, or serology. Cytomegalo-37 (1.4%) were neutropenic for 14 days after late engraftment, and 16 (0.6%) were neutropenic for 14 days even though envirus was a copathogen in six patients, and Aspergillus species were copathogens in two. Two patients with brain abscesses graftment had not occurred. However, there were no hematologic data for 1,856 control patients at FHCRC, most of whom did not have evidence of pulmonary infection. Blood cultures were positive for Nocardia species in five cases, including both had undergone transplantation before 1988. Therefore, the rate of neutropenia could not be assessed in the control population. cases in which cultures of an indwelling catheter tip were positive.
Thirteen (52%) of the 25 patients with invasive nocardiosis had active GVHD before the onset of nocardiosis. Patients at Cutaneous disease occurred at purulent catheter exit sites (n Å 4) or at the catheter tip (n Å 2) or as abscesses in scattered FHCRC were evaluated on day 90. GVHD was active in the 2 weeks preceding infection in eight (44%: two with acute sites (the preauricular region, neck and contiguous thyroid gland, forearm, shoulder, buttock, thigh, shin, or great toe).
GVHD and six with chronic GVHD) of the patients with nocardiosis at FHCRC. Acute or chronic GVHD preceded infection Purulence was the only common sign reported in all catheterrelated cases.
in 15 (83%) of 18 allogeneic transplant recipients with nocardiosis at FHCRC and occurred in 3,622 (80%) of the 4,552 Patient 3 had the catheter removed on the first day of infection; cultures of the line exit site were still positive on days 5 controls (P Å 1.00). Therapy with four double-strength trimethoprim-sulfamethand 7, and became negative on days 8 and 9. Patient 6 underwent debridement of a purulent catheter exit site from which oxazole tablets per week was insufficient for preventing nocardiosis in 10 (40%) of the 25 patients. Other forms of PCP both Aspergillus and Nocardia species were recovered; serial cultures were not performed. In the case of patient 12, Nocardia prophylaxis included dapsone (n Å 2) and aerosolized pentamidine (n Å 4). Patients who did not receive PCP prophylaxis was cultured from aspirate from a small, purulent mass that had developed at a previous catheter tunnel site. The wound included the patient with nocardiosis before transplantation, three who discontinued therapy with trimethoprim-sulfamethwas explored, debrided, and packed. Although this patient received double-strength trimethoprim-sulfamethoxazole four oxazole in the month before nocardiosis was diagnosed, four who underwent transplantation before 1980, and one of the times daily, local recurrence was documented 2 months later. The patient died 4 months later of other causes. Patient 15 had patients described in the literature. At FHCRC, the routine use of trimethoprim-sulfamethoxaa 6-day history of soreness in his shoulder (at the catheter insertion site), which was attributed to the use of a backpack.
zole for PCP prophylaxis began in 1980, but entry of inpatient medication data was not computerized until 1995. Therefore, Repeated cultures of specimens from the exit site were positive 2 and 5 days after the first culture was performed; the line was the rate of use of trimethoprim-sulfamethoxazole cannot be assessed in the control population. In 1995, 92 (36%) of 253 removed, and the site was debrided on day 2, without further recurrence of the infection. that the survival rate for patients with nocardiosis at FHCRC was 66% at 1 year and 34% at 6 years; this rate was marginally lower than that for the controls (P Å .07). prim-sulfamethoxazole before they were discharged and began receiving treatment as outpatients. It is estimated that between Discussion 80% and 90% of outpatients at FHCRC receive trimethoprimsulfamethoxazole.
Although marrow transplant recipients are severely immunocompromised, reports of nocardiosis are surprisingly rare Radiographic findings. Nodules, with or without infiltrates, were the major radiographic manifestation of pulmonary nocaramong these patients [1 -4] , and our review confirms the low incidence (0.3%). We found that the incidence of nocardiosis diosis and were found in 12 (48%) of 25 patients (table 2) . Three additional patients had pulmonary nodules, but examinavaried somewhat by institution; at FHCRC, it was 0.3%; at MSKCC, it was 0.1%; and at HLMCC, it was 0.7%. The incition of biopsy specimens did not reveal nocardiosis. Infiltrates usually occurred with, rather than independent of, nodules.
dence of nocardiosis does not appear to have risen over time. Chest radiographic findings were normal for eight patients with other types of invasive disease (i.e., three with catheter-related infections, three with localized cutaneous infections, and two with brain abscesses).
Histological findings. Specimens submitted for pathological examination were examined histologically for tissue reactions and were stained. The 9 specimens examined for tissue reactions displayed mixed inflammatory infiltrates consisting of lymphocytes, histiocytes, plasma cells, and neutrophils; these specimens included abscesses (n Å 6), granulomas (n Å 2), and granulation tissue (n Å 1). For example, patient 4 had a 3-mm caseating granuloma in a subpleural nodule.
A combination of three stains yielded a specific diagnosis in most of the cases. Gram staining demonstrated filamentous organisms, branched beading organisms, or long rod-like forms with a coccal appearance. The Ziehl-Neelsen stain [18] (with use of acid alcohol for decolorization) was positive for acidfast organisms in three of 9 cases; in one instance, the organ- , mortality was increased among patients with disseminated disease involving two or more noncontiguous orthan do other infections, it may not be reported to the transplantation center, and the diagnosis might therefore be missed. gans. The mechanism by which Nocardia disseminate is beThe majority of isolates in this case series were N. asteroides complex. Microbiological methods cannot be used to differenlieved to be hematogenous despite the absence of blood cultures positive for Nocardia [2] . The organism was isolated tiate between the three species of this complex, N. asteroides, N. farcinica, and N. nova [20] . However, differentiation is not from multiple sites in six of our patients, and five patients had documented bacteremia. Table 1 shows that two of the critical when sulfonamide agents are used for treatment. On the other hand, it is important to identify N. farcinica when patients in this series also had an infected central venous catheter, implicating the line as the source of bacteremia. A adjunctive antibiotic therapy is considered because N. farcinica is highly resistant to various antibiotics, including third-generapositive blood culture could provide evidence that nocardiosis is being disseminated when the organism is isolated tion cephalosporins. Resistance to cefamandole and tobramycin (zone of inhibition, õ20 mm), as determined by the Kirbyfrom a superficial site that can become colonized such as sputum [31] . Bauer disk diffusion method, has been suggested as one criteria for distinguishing isolates [21] . Although seven of the N. asterWe did not identify any independent risk factors for nocardiosis among the marrow transplant recipients in this study. A oides complex isolates in our series were tested for susceptibility by the disk diffusion method, none were tested against combination of defects in the numbers and function of lymphocytes, monocytes, and polymorphonuclear leukocytes apparcefamandole or tobramycin. The impact of drug resistance will generally remain minor as long as resistance to sulfonamides ently contributes to susceptibility to nocardiosis [32 -33] , but in our series the presence of neutropenia during the 2 weeks does not appear.
The most frequent initial site of nocardiosis due to N. asteropreceding the diagnosis of nocardiosis was not a significant factor. Prophylaxis with trimethoprim-sulfamethoxazole for ides complex has been the lung (79% of cases [22 -26] ), which was the initial site in 55% of our cases. Our marrow transplant PCP is potentially protective against nocardiosis. Since the institution of trimethoprim-sulfamethoxazole prophylaxis for recipients developed nocardiosis in the postengraftment period (days 30 -90) or in the late posttransplantation period (day 90 all renal transplant recipients at the University of Minnesota (Minneapolis, MN), investigators have noted a decrease in the or later). Radiographic findings typically included nodules, with or without infiltrates, which often suggested fungal infecincidence of infections due to Nocardia and Listeria species, as well as those due to P. carinii [12] . tion; the Nocardia organism was isolated with viral or fungal copathogens in some cases. Lung involvement occurred in 88% Evaluation of data from 31 renal transplantation centers led to the recommendation that whenever the incidence of nocar-(77 of 88 cases) of renal transplant recipients [12] and 81% (17 of 21 cases) of heart transplant recipients [26] . Although diosis is §3%, trimethoprim-sulfamethoxazole prophylaxis specifically for Nocardia is indicated [12] . A similar recomthe clinical presentation varied in these studies, the most common form of nocardiosis was lung disease, reflecting airborne mendation has not been noted for either nocardia [1 -4] or listeria [34] infections in other reports, nor was it noted in the transmission of Nocardia into the respiratory tract.
Cutaneous involvement can result from hematogenous dispresent series of marrow transplant recipients. Most of the patients in this study were receiving intensive semination or primary inoculation through the skin. Primary cutaneous nocardiosis has historically been associated with enimmunosuppresive agents (corticosteroids or cyclosporine), but most transplant recipients do receive these medications. It is of vironmental exposure or trauma to the affected site [27] and may be more commonly caused by N. brasiliensis [28 -30] .
interest that the incidence of nocardiosis among renal transplant recipients receiving cyclosporine/prednisone was 0.7% (9 of For one patient in our series, the portal of entry was a desquamative leg lesion caused by GVHD. This patient had not had 1,255), whereas it was 2.6% (4 of 154) among renal transplant recipients who received azathioprine/prednisone (P õ .05) [11] . any notable exposure to soil after receiving her transplant; however, severely immunocompromised patients should avoid
The reason for this threefold decrease in the incidence of nocardiosis among cyclosporine-treated patients was not evident. gardening and other contact with soil. For the four patients with catheter exit-site infections, purulence was common, and During the revision of this manuscript, a series of six case reports of nocardial infections in marrow transplant recipients cultures remained positive for £1 week after surgical debridement was performed.
at Vanderbilt University (Nashville, TN) was published [35] ; the authors compared their cases with the four previously deThe majority of patients in the present study survived nocardiosis. Although many of these patients underwent adscribed cases [1 -4] . In that series, an autologous transplant recipient who received oral prednisone for 2 weeks developed junctive surgical debridement or resection because fungal infections were clinically suspected, the contribution of surpulmonary infection due to Blastomyces and Nocardia; the patient had had significant exposure to soil during 4 months gery to the resolution of the infections is difficult to assess. In a retrospective study examining factors affecting survival after transplantation. The overall rate of nocardial infection among the population in this series was 0.7% (6 of 856 
